For people with a stiff, failing aortic valve, transcatheter aortic valve replacement (TAVR) offers a shorter, easier recovery than surgical replacement of the valve. TAVR is currently approved only for people in whom surgery is too risky. But refinements to the devices and the procedure itself (which is increasingly being done without general anesthesia) are driving a trend toward the use of TAVR in a broader group of people.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.